Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Northwest Bioth Cmn (NWBO)

Northwest Bioth Cmn (NWBO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 697,738
  • Shares Outstanding, K 761,556
  • Annual Sales, $ 2,410 K
  • Annual Income, $ -20,300 K
  • 60-Month Beta 1.46
  • Price/Sales 278.05
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/10/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3101 +184.10%
on 08/24/20
0.9640 -8.61%
on 09/17/20
+0.5565 (+171.49%)
since 08/21/20
3-Month
0.2611 +237.42%
on 07/23/20
0.9640 -8.61%
on 09/17/20
+0.5110 (+138.11%)
since 06/22/20
52-Week
0.1400 +529.29%
on 02/07/20
0.9640 -8.61%
on 09/17/20
+0.6350 (+258.13%)
since 09/20/19

Most Recent Stories

More News
Northwest Biotherapeutics Acquires Flaskworks

, /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, today announced that the Company...

NWBO : 0.8897 (-2.89%)
Northwest Biotherapeutics Acquires Flaskworks

BETHESDA, Md. , Sept. 1, 2020 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ® personalized immune therapies for solid tumor cancers,...

NWBO : 0.8897 (-2.89%)
NW Bio Accelerating Sawston Plant Phase I Buildout

, /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, today announced that the Company...

NWBO : 0.8897 (-2.89%)
NW Bio Accelerating Sawston Plant Phase I Buildout

BETHESDA, Md. , Aug. 27, 2020 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ® personalized immune therapies for solid tumor cancers,...

NWBO : 0.8897 (-2.89%)
Northwest Biotherapeutics Announces $5 Million Financing

, /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, today announced that the Company has...

NWBO : 0.8897 (-2.89%)
Northwest Biotherapeutics Announces $5 Million Financing

BETHESDA, Md. , Aug. 21, 2020 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ® personalized immune therapies for solid tumor cancers,...

NWBO : 0.8897 (-2.89%)
NW Bio Announces Completion of Further Data Gathering For Phase III Trial

, /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO)("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that the remaining...

NWBO : 0.8897 (-2.89%)
NW Bio Announces Completion of Further Data Gathering For Phase III Trial

BETHESDA, Md. , Aug. 19, 2020 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO)("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers,...

NWBO : 0.8897 (-2.89%)
Northwest Biotherapeutics Announces $8 Million Financing

, /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO)("NW Bio"), a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, today announced that the Company has...

NWBO : 0.8897 (-2.89%)
Northwest Biotherapeutics Announces $8 Million Financing

BETHESDA, Md. , Aug. 11, 2020 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO)("NW Bio"), a biotechnology company developing DCVax ® personalized immune therapies for solid tumor cancers,...

NWBO : 0.8897 (-2.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade NWBO with:

Key Turning Points

2nd Resistance Point 0.9647
1st Resistance Point 0.9405
Last Price 0.8897
1st Support Level 0.8810
2nd Support Level 0.8457

See More

52-Week High 0.9640
Last Price 0.8897
Fibonacci 61.8% 0.6492
Fibonacci 50% 0.5520
Fibonacci 38.2% 0.4548
52-Week Low 0.1400

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar